Cargando…
Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines
BACKGROUND: Malaria is one of the most prevalent tropical infectious diseases. Since recently cases of artemisinin resistance were reported, novel anti-malarial drugs are required which differ from artemisinins in structure and biological target. The plasmodial glycogen synthase kinase-3 (PfGSK-3) w...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429710/ https://www.ncbi.nlm.nih.gov/pubmed/30898128 http://dx.doi.org/10.1186/s12936-019-2725-y |
_version_ | 1783405645928595456 |
---|---|
author | Masch, Andreas Nasereddin, Abed Alder, Arne Bird, Megan J. Schweda, Sandra I. Preu, Lutz Doerig, Christian Dzikowski, Ron Gilberger, Tim W. Kunick, Conrad |
author_facet | Masch, Andreas Nasereddin, Abed Alder, Arne Bird, Megan J. Schweda, Sandra I. Preu, Lutz Doerig, Christian Dzikowski, Ron Gilberger, Tim W. Kunick, Conrad |
author_sort | Masch, Andreas |
collection | PubMed |
description | BACKGROUND: Malaria is one of the most prevalent tropical infectious diseases. Since recently cases of artemisinin resistance were reported, novel anti-malarial drugs are required which differ from artemisinins in structure and biological target. The plasmodial glycogen synthase kinase-3 (PfGSK-3) was suggested as a new anti-malarial drug target. 4-Phenylthieno[2,3-b]pyridines were previously identified as selective PfGSK-3 inhibitors with antiplasmodial activity. The present study aims at identifying a molecular position on this scaffold for the attachment of side chains in order to improve solubility and antiplasmodial activity. Furthermore, the role of axial chirality in the compound class for antiplasmodial activity and PfGSK-3 inhibition was investigated. METHODS: 4-Phenylthieno[2,3-b]pyridines with substituents in 4-position of the phenyl ring were docked into the ATP binding site of PfGSK-3. The compounds were synthesized employing a Thorpe reaction as final step. The enantiomers of one congener were separated by chiral HPLC. All derivatives were tested for inhibition of asexual erythrocytic stages of transgenic NF54-luc Plasmodium falciparum. Selected compounds with promising antiplasmodial activity were further evaluated for inhibition of HEK293 cells as well as inhibition of isolated PfGSK-3 and HsGSK-3. The kinetic aqueous solubility was assessed by laser nephelometry. RESULTS: The para position at the 4-phenyl ring of the title compounds was identified as a suitable point for the attachment of side chains. While alkoxy substituents in this position led to decreased antiplasmodial activity, alkylamino groups retained antiparasitic potency. The most promising of these congeners (4h) was investigated in detail. This compound is a selective PfGSK-3 inhibitor (versus the human GSK-3 orthologue), and exhibits improved antiplasmodial activity in vitro as well as better solubility in aqueous media than its unsubstituted parent structure. The derivative 4b was separated into the atropisomers, and it was shown that the (+)-enantiomer acts as eutomer. CONCLUSIONS: The attachment of alkylamino side chains leads to the improvement of antiplasmodial activity and aqueous solubility of selective PfGSK-inhibitors belonging to the class of 4-phenylthieno[2,3-b]pyridines. These molecules show axial chirality, a feature of high impact for biological activity. The findings can be exploited for the development of improved selective PfGSK-3 inhibitors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12936-019-2725-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6429710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64297102019-04-04 Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines Masch, Andreas Nasereddin, Abed Alder, Arne Bird, Megan J. Schweda, Sandra I. Preu, Lutz Doerig, Christian Dzikowski, Ron Gilberger, Tim W. Kunick, Conrad Malar J Research BACKGROUND: Malaria is one of the most prevalent tropical infectious diseases. Since recently cases of artemisinin resistance were reported, novel anti-malarial drugs are required which differ from artemisinins in structure and biological target. The plasmodial glycogen synthase kinase-3 (PfGSK-3) was suggested as a new anti-malarial drug target. 4-Phenylthieno[2,3-b]pyridines were previously identified as selective PfGSK-3 inhibitors with antiplasmodial activity. The present study aims at identifying a molecular position on this scaffold for the attachment of side chains in order to improve solubility and antiplasmodial activity. Furthermore, the role of axial chirality in the compound class for antiplasmodial activity and PfGSK-3 inhibition was investigated. METHODS: 4-Phenylthieno[2,3-b]pyridines with substituents in 4-position of the phenyl ring were docked into the ATP binding site of PfGSK-3. The compounds were synthesized employing a Thorpe reaction as final step. The enantiomers of one congener were separated by chiral HPLC. All derivatives were tested for inhibition of asexual erythrocytic stages of transgenic NF54-luc Plasmodium falciparum. Selected compounds with promising antiplasmodial activity were further evaluated for inhibition of HEK293 cells as well as inhibition of isolated PfGSK-3 and HsGSK-3. The kinetic aqueous solubility was assessed by laser nephelometry. RESULTS: The para position at the 4-phenyl ring of the title compounds was identified as a suitable point for the attachment of side chains. While alkoxy substituents in this position led to decreased antiplasmodial activity, alkylamino groups retained antiparasitic potency. The most promising of these congeners (4h) was investigated in detail. This compound is a selective PfGSK-3 inhibitor (versus the human GSK-3 orthologue), and exhibits improved antiplasmodial activity in vitro as well as better solubility in aqueous media than its unsubstituted parent structure. The derivative 4b was separated into the atropisomers, and it was shown that the (+)-enantiomer acts as eutomer. CONCLUSIONS: The attachment of alkylamino side chains leads to the improvement of antiplasmodial activity and aqueous solubility of selective PfGSK-inhibitors belonging to the class of 4-phenylthieno[2,3-b]pyridines. These molecules show axial chirality, a feature of high impact for biological activity. The findings can be exploited for the development of improved selective PfGSK-3 inhibitors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12936-019-2725-y) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-21 /pmc/articles/PMC6429710/ /pubmed/30898128 http://dx.doi.org/10.1186/s12936-019-2725-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Masch, Andreas Nasereddin, Abed Alder, Arne Bird, Megan J. Schweda, Sandra I. Preu, Lutz Doerig, Christian Dzikowski, Ron Gilberger, Tim W. Kunick, Conrad Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines |
title | Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines |
title_full | Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines |
title_fullStr | Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines |
title_full_unstemmed | Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines |
title_short | Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines |
title_sort | structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429710/ https://www.ncbi.nlm.nih.gov/pubmed/30898128 http://dx.doi.org/10.1186/s12936-019-2725-y |
work_keys_str_mv | AT maschandreas structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines AT nasereddinabed structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines AT alderarne structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines AT birdmeganj structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines AT schwedasandrai structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines AT preulutz structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines AT doerigchristian structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines AT dzikowskiron structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines AT gilbergertimw structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines AT kunickconrad structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines |